Zhongguo aizheng zazhi (Jun 2022)

China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasm (2022 edition)

  • Society of Neuroendocrine Neoplasm of China Anti-Cancer Association

DOI
https://doi.org/10.19401/j.cnki.1007-3639.2022.06.010
Journal volume & issue
Vol. 32, no. 6
pp. 545 – 579

Abstract

Read online

Neuroendocrine neoplasm (NEN) is a kind of rare tumor that originated from peptidergic neurons and neuroendocrine cells, which has neuroendocrine differentiation and expresses neuroendocrine markers. NEN occurs in all parts of the body, especially in lung, stomach, intestine and pancreas. Domestic and international research data suggested that the incidences of NEN were rising. The results of epidemiological investigation showed that compared with other types of tumors, the incidences of NEN increased more significantly. On the basis of existing evidence, combined with domestic and international guidelines and consensus, the Society of Neuroendocrine Neoplasm of China Anti-Cancer Association has formulated its first guideline for diagnosis and treatment of NEN as reference for clinical physicians.

Keywords